Can the Marketing Authorisation Holder system improve the ESG performance of pharmaceutical manufacturers?
The results offer actionable policy recommendations for refining the MAH system and promoting the sustainable development of pharmaceutical manufacturing firms. This study not only expands the research boundary of the economic consequences of the MAH system, but also affirms the key role of institutional innovation in the sustainable development of enterprises.
Authors
- Jiajing Li (ORCID: https://orcid.org/0000-0003-1804-4258)
Institutions
- Shanghai University of Finance and Economics (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fpubh.2025.1587028
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00